Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if HIMS & HERS HEALTH INC (NYSE:HIMS) is suited for growth investing. Investors should of course do their own research, but we spotted HIMS & HERS HEALTH INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.
Key Considerations for Growth Investors.
The Return on Equity(ROE) of HIMS & HERS HEALTH INC is 23.01%, which is a strong number. This indicates the company's ability to generate favorable returns for shareholders and reflects its effective management of resources.
HIMS & HERS HEALTH INC has a strong history of beating EPS estimates in the last 4 quarters, signaling its ability to consistently exceed market expectations. This indicates the company's strong financial performance and its potential for creating shareholder value.
With notable 1-year revenue growth of 56.7%, HIMS & HERS HEALTH INC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
HIMS & HERS HEALTH INC has achieved 77.13% growth in its revenue over the previous quarter, signaling positive momentum in its financial performance and potential market opportunities.
The operating margin of HIMS & HERS HEALTH INC has seen steady growth over the past year, signaling improved profitability. This trend indicates the company's effective cost management and its ability to generate higher returns.
The free cash flow (FCF) of HIMS & HERS HEALTH INC has seen steady growth over the past year, indicating enhanced cash flow generation and financial health. This trend underscores the company's effective capital management and its ability to generate sustainable cash flows.
HIMS & HERS HEALTH INC has shown positive momentum in its earnings per share (EPS) on a quarter-to-quarter (Q2Q) basis, with a 900.0% increase. This reflects the company's successful execution of its business strategies and its commitment to delivering improved financial results.
Over the past 3 months, analysts have adjusted their EPS Estimate for HIMS & HERS HEALTH INC with a 239.0% change. This highlights the evolving outlook on the company's EPS potential.
The recent financial report of HIMS & HERS HEALTH INC demonstrates a 900.0% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
HIMS & HERS HEALTH INC shows accelerating EPS growth: when comparing the current Q2Q growth of 900.0% to the previous year Q2Q growth of 55.56%, we see the growth rate improving.
A complete fundamental analysis of NYSE:HIMS
At ChartMill, a crucial aspect of their analysis is the assignment of a Fundamental Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous fundamental indicators and properties.
Overall HIMS gets a fundamental rating of 5 out of 10. We evaluated HIMS against 111 industry peers in the Health Care Providers & Services industry. While HIMS has a great health rating, its profitability is only average at the moment. HIMS is not valued too expensively and it also shows a decent growth rate.
More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.
Keep in mind
This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.